Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 25/03/20251 min de leitura
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
Tradução automática local · Idioma original da fonte
Resumo
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →